slotkoers
Shanghai S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
58,12
CNY
|
+0,64%
|
|
+2,22%
|
+39,51%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
12.816
|
13.590
|
8.856
|
18.747
|
26.154
|
-
|
-
|
Bedrijfswaarde
1 |
12.816
|
13.590
|
8.856
|
18.747
|
26.154
|
26.154
|
26.154
|
K/w-verhouding
|
-33,9
x
|
755
x
|
65,6
x
|
29,1
x
|
25,2
x
|
20,1
x
|
16,4
x
|
Dividendrendement
|
-
|
-
|
-
|
0,96%
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
22.849
x
|
25,6
x
|
-
|
9,32
x
|
8,83
x
|
7,17
x
|
5,96
x
|
Bedrijfswaarde/omzet
|
22.849
x
|
25,6
x
|
-
|
9,32
x
|
8,83
x
|
7,17
x
|
5,96
x
|
Bedrijfswaarde/EBITDA
|
-
|
-
|
-
|
27
x
|
24,5
x
|
19,8
x
|
15,9
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
-
|
30.896.517
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
4,45
x
|
4,57
x
|
-
|
4,69
x
|
5,4
x
|
4,37
x
|
3,54
x
|
Aantal aandelen (in duizenden)
|
450.000
|
450.000
|
450.000
|
450.000
|
450.000
|
-
|
-
|
Referentieprijs
2 |
28,48
|
30,20
|
19,68
|
41,66
|
58,12
|
58,12
|
58,12
|
Datum van publicatie
|
25/02/21
|
25/02/22
|
27/02/23
|
23/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
0,5609
|
530,1
|
-
|
2.012
|
2.961
|
3.646
|
4.389
|
EBITDA
1 |
-
|
-
|
-
|
695,4
|
1.066
|
1.318
|
1.642
|
Bedrijfsresultaat (EBIT)
1 |
-310,5
|
21,83
|
-
|
660,7
|
1.076
|
1.364
|
1.702
|
Operationele Marge
|
-55.348,85%
|
4,12%
|
-
|
32,83%
|
36,36%
|
37,4%
|
38,79%
|
Resultaat voor belastingen (EBT)
1 |
-310,5
|
18,27
|
-
|
659,2
|
1.074
|
1.360
|
1.700
|
Nettowinst (verlies)
1 |
-310,5
|
18,27
|
133
|
644,9
|
1.037
|
1.298
|
1.598
|
Nettomarge
|
-55.360,17%
|
3,45%
|
-
|
32,04%
|
35,02%
|
35,62%
|
36,4%
|
WPA
2 |
-0,8400
|
0,0400
|
0,3000
|
1,430
|
2,305
|
2,885
|
3,550
|
Free Cash Flow
|
-
|
-
|
-
|
606,8
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
-
|
30,15%
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
87,25%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
94,09%
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
0,4000
|
-
|
-
|
-
|
Datum van publicatie
|
25/02/21
|
25/02/22
|
27/02/23
|
23/02/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
607
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-25,3%
|
0,62%
|
-
|
18%
|
21,5%
|
21,8%
|
21,7%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
14,7%
|
20,1%
|
20,5%
|
21,1%
|
Totale activa
1 |
-
|
-
|
-
|
4.384
|
5.159
|
6.334
|
7.571
|
Nettoactief per aandeel
2 |
6,400
|
6,610
|
-
|
8,890
|
10,80
|
13,30
|
16,40
|
Cashflow per aandeel
2 |
-0,4400
|
0,0700
|
-
|
1,500
|
1,930
|
2,520
|
3,110
|
Capex
1 |
-
|
-
|
-
|
67,9
|
87
|
74
|
75
|
Capex/omzet
|
-
|
-
|
-
|
3,37%
|
2,94%
|
2,03%
|
1,71%
|
Datum van publicatie
|
25/02/21
|
25/02/22
|
27/02/23
|
23/02/24
|
-
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +39,51% | 3,61 mld. | | +11,91% | 118 mld. | | +11,60% | 106 mld. | | -4,68% | 24,28 mld. | | -0,82% | 21,96 mld. | | -10,12% | 18,16 mld. | | -42,12% | 16,37 mld. | | -17,47% | 15,56 mld. | | +2,77% | 13,63 mld. | | +34,58% | 12,27 mld. |
Biotherapeutische geneesmiddelen
|